PHILADELPHIA, PA / ACCESSWIRE / October 31, 2020 / Kaskela Law LLC announces that it is investigating Alnylam Pharmaceuticals, Inc. (“Alnylam”) (NASDAQ:ALNY) on behalf of the company’s stockholders.

The investigation seeks to determine whether Alnylam and/or the company’s officers and directors have violated the securities laws or breached their fiduciary duties and whether Alnylam investors have been harmed as a result of such actions.

Alnylam stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258-1585 or (888) 715-1740, or via email at [email protected], to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/alnylam-pharmaceuticals-inc/.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC, please visit www.kaskelalaw.com.

CONTACT:
D. Seamus Kaskela, Esq.

KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258-1585
(888) 715-1740
[email protected]
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE: Kaskela Law LLC

View source version on accesswire.com:
https://www.accesswire.com/613651/Kaskela-Law-LLC-Announces-Stockholder-Investigation-of-Alnylam-Pharmaceuticals-Inc–ALNY